Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
Apple
AAPL
|
$1.03B |
| 2 |
Broadcom
AVGO
|
$1.01B |
| 3 |
SPDR Portfolio S&P 500 ETF
SPLG
|
$892M |
| 4 |
Amazon
AMZN
|
$876M |
| 5 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
$765M |
Top Sells
| 1 |
Advanced Micro Devices
AMD
|
$459M |
| 2 |
Yum China
YUMC
|
$421M |
| 3 |
Merck
MRK
|
$362M |
| 4 |
ASML
ASML
|
$313M |
| 5 |
Microchip Technology
MCHP
|
$298M |
Sector Composition
| 1 | Technology | 24.74% |
| 2 | Financials | 12.44% |
| 3 | Industrials | 11.72% |
| 4 | Healthcare | 10.66% |
| 5 | Consumer Discretionary | 10.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Vivid Seats
SEAT
$103M
| $83K | ﹤0.01% |
1,121
-4,423
| -80% | -$327K |
|
3527
X4 Pharmaceuticals
XFOR
$78.6M
| $82.8K | ﹤0.01% |
4,126
+840
| +26% | +$16.9K |
|
|
PSTX
3528
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
| $82.6K | ﹤0.01% |
28,865
-824
| -3% | -$2.36K |
|
|
INZY
3529
DELISTED
Inozyme Pharma
INZY
| $80.7K | ﹤0.01% |
15,423
-981
| -6% | -$5.13K |
|
3530
Domo
DOMO
$603M
| $79.7K | ﹤0.01% |
10,611
-10,038
| -49% | -$75.4K |
|
3531
Melco Resorts & Entertainment
MLCO
$3.8B
| $78.2K | ﹤0.01% |
10,038
-2,094
| -17% | -$16.3K |
|
3532
Pyxis Oncology
PYXS
$118M
| $77.7K | ﹤0.01% |
21,175
-928
| -4% | -$3.41K |
|
3533
Achieve Life Sciences
ACHV
$145M
| $76.2K | ﹤0.01% |
16,073
-141
| -0.9% | -$668 |
|
3534
Black Diamond Therapeutics
BDTX
$167M
| $76K | ﹤0.01% |
17,480
-694,902
| -98% | -$3.02M |
|
3535
Lucas GC Ltd
LGCL
$50.7M
| $73.4K | ﹤0.01% |
+64,958
| New | +$73.4K |
|
3536
Acacia Research
ACTG
$318M
| $69.6K | ﹤0.01% |
14,937
-15,535
| -51% | -$72.4K |
|
|
NKLA
3537
DELISTED
Nikola Corporation Common Stock
NKLA
| $68.9K | ﹤0.01% |
15,039
+52
| +0.3% | +$238 |
|
|
AUTL
3538
Autolus Therapeutics
AUTL
$389M
| $68.1K | ﹤0.01% |
18,748
+2,424
| +15% | +$8.8K |
|
3539
Planet Image International
YIBO
$72.2M
| $67.3K | ﹤0.01% |
+22,578
| New | +$67.3K |
|
3540
AC Immune
ACIU
$229M
| $65.6K | ﹤0.01% |
17,362
+5,471
| +46% | +$20.7K |
|
3541
Cabaletta Bio
CABA
$155M
| $65.4K | ﹤0.01% |
13,865
-1,459
| -10% | -$6.89K |
|
3542
Compass Therapeutics
CMPX
$590M
| $65.3K | ﹤0.01% |
35,465
-1,937
| -5% | -$3.56K |
|
3543
Trevi Therapeutics
TRVI
$854M
| $65.1K | ﹤0.01% |
19,488
-235
| -1% | -$785 |
|
3544
Shattuck Labs
STTK
$74.2M
| $64.2K | ﹤0.01% |
18,389
-101
| -0.5% | -$352 |
|
3545
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $63.7K | ﹤0.01% |
61,229
+9,128
| +18% | +$9.49K |
|
3546
Inovio Pharmaceuticals
INO
$148M
| $63.7K | ﹤0.01% |
11,013
-482
| -4% | -$2.79K |
|
|
BTC
3547
Grayscale Bitcoin Mini Trust ETF
BTC
$4.88B
| $63.2K | ﹤0.01% |
+2,247
| New | +$63.2K |
|
|
KG
3548
Kestrel Group, Ltd.
KG
$200M
| $63.1K | ﹤0.01% |
1,783
-83
| -4% | -$2.94K |
|
|
BLUE
3549
DELISTED
bluebird bio
BLUE
| $62.3K | ﹤0.01% |
5,998
+1,603
| +36% | +$16.7K |
|
3550
Outset Medical
OM
$249M
| $62.1K | ﹤0.01% |
6,112
+27
| +0.4% | +$274 |
|